|
Gujarat FDCA approves 161 & 181 pharma plants based on MoUs signed in VGS-2017 and VGS-2019
|
|
Shardul Nautiyal, Mumbai
February 15 , 2021
|
|
|
The Gujarat Food and Drug Control Administration (FDCA) has approved and commissioned 161 pharmaceutical plants based on 249 MoUs signed with pharma companies in Vibrant Gujarat Global Summit (VGGS)-2017 and commissioned 181 pharmaceutical plants based on 273 MoUs signed with pharma companies in VGGS-2019.
The Gujarat government signed MoUs worth Rs. 15,000 crore with both Indian and international companies in the pharma sector during Vibrant Gujarat Global Summit- 2017.
In VGGS-2017 alone, Australia, Canada, Denmark, France, Japan, The Netherlands, Poland, UAE, UK, USA, Sweden and Singapore were the partner countries in the summit with 1,250 companies.
“Gujarat commissioned 44 pharmaceutical plants in 2011, 79 in 2013 and 160 in 2015 based on VGGS summit MoUs. This has helped promote Gujarat’s pharma manufacturing strength and align it with Prime Minister Narendra Modi ‘Make in India’ campaign,” according to Gujarat FDCA Commissioner Dr H G Koshia.
Over 3,300 pharma manufacturing units are located across the state in four large clusters with 5 Special Economic Zones in an area of over 1500 hectares, as per government of Gujarat data.
Accounting for nearly 40 per cent of India’s pharma production and 28 per cent of pharma exports, Gujarat saw an increase in pharma exports in the past one decade with US$ 3,060 million worth of exports in 2016 from a quantum of exports worth US$ 562 million in 2006.
As a part of its broader engagement with organisations and academia to develop medical devices sector, NIPER Ahmedabad is also being developed as a National Centre for Medical Devices (NCMD) which will provide a conducive environment to nurture innovators and industry to further the vision of quality medical device manufacturing.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|